The Ultimate Resource for Pharmaceutical SOPs and Best Practices
To define a validated and regulatory-compliant method for the determination of particulate matter in injectable formulations using light obscuration particle count test, ensuring conformance to compendial limits and product quality standards.
Click to read the full article.
To outline a validated procedure for determining the osmolality of sterile injectable pharmaceutical products using a freezing point depression osmometer, to ensure formulation safety, comfort, and compatibility with physiological conditions.
Click to read the full article.
To define the validated procedure for developing tonicity testing methods for sterile pharmaceutical products including injectables and ophthalmics, ensuring patient safety by evaluating isotonicity through suitable analytical and biological methods.
Click to read the full article.
To establish a standardized and validated procedure for determining the extractable volume of sterile pharmaceutical products in containers such as ampoules, vials, syringes, and bottles, ensuring product compliance with pharmacopeial requirements.
Click to read the full article.
To define a validated and comprehensive procedure for quality testing of Water for Injection (WFI) used in sterile pharmaceutical production, covering physicochemical parameters, microbial contamination, and organic impurities in accordance with USP, Ph. Eur., and IP standards.
Click to read the full article.
To define the validated procedure for identification and quantification of antimicrobial preservatives in multi-dose injectable pharmaceutical formulations using chromatographic and spectroscopic techniques, ensuring patient safety and regulatory compliance.
Click to read the full article.
To define a standardized and validated procedure for compatibility testing of active pharmaceutical ingredients (APIs) with commonly used diluents in sterile injectable formulations, ensuring product safety, efficacy, and physical-chemical stability.
Click to read the full article.
To establish a validated analytical method for the detection and quantification of benzyl alcohol in parenteral formulations using HPLC with UV detection, ensuring compliance with pharmacopeial requirements and patient safety.
Click to read the full article.
To outline a validated and standardized procedure for developing methods to quantify preservatives such as methylparaben, propylparaben, benzyl alcohol, and phenol in various pharmaceutical dosage forms using HPLC or UV-visible spectrophotometry.
Click to read the full article.
To define a validated analytical procedure for the development of a stability-indicating method (SIM) for lyophilized injectable formulations, capable of distinguishing the active pharmaceutical ingredient (API) from its degradation products under forced degradation and stability conditions.
Click to read the full article.